GL1X · GenesisL1 explorer

Research workbench

Crystal structure of PLK1 in complex with a pyrimidodiazepinone inhibitor

Analyse Crystal structure of PLK1 in complex with a pyrimidodiazepinone inhibitor in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
4J52
Type
protein
Length
293 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
SERINE/THREONINE-protein kinase PLK1
EC
2.7.11.21
UniProt
P53350
Ligands
1J3, ZN
Pockets
3 · best druggability 0.71

Structure

x-ray diffraction · 1 distinct chain · 34% helix, 19% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ASERINE/THREONINE-protein kinase PLK1 (EC 2.7.11.21)protein29334% helix, 19% strandP53350

Ligands and binding sites

  • 1J3 · 4-{[(7R)-9-cyclopentyl-7-ethenyl-7-fluoro-5-methyl-6-oxo-6,7,8,9-tetrahydro-5H-pyrimido[4,5-b][1,4]diazepin-2-yl]amino}-3-methoxy-N-(4-methylpiperazin-1-yl)benzamide · ligand · chains A
  • ZN · Zinc ion · metal · chains A
  • ACT · Acetate ion · additive · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

3 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
14530.710.81451J3
2930.430.7824ACT
3630.330.7716empty

Compared structures

  • 4J52 · Crystal structure of PLK1 in complex with a pyrimidodiazepi inhibitor · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.